Health Care & Life Sciences » Biotechnology | Minerva Neurosciences Inc.

Minerva Neurosciences Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,818.30
18,580.70
32,284.70
83,060.60
128,241.20
88,097.30
Other Current Assets
0.90
757.00
1,196.10
803.20
1,299.20
1,921.10
Total Current Assets
1,819.20
19,337.70
33,480.80
83,863.90
129,540.40
90,018.40
Net Property, Plant & Equipment
3.20
43.40
26.20
9.60
50.90
33.50
Total Investments and Advances
-
-
-
-
5,023.00
-
Intangible Assets
26,918.40
49,069.40
49,069.40
49,069.40
49,069.40
49,069.40
Other Assets
434.00
-
-
-
14.80
14.80
Total Assets
29,174.80
68,450.50
82,576.40
132,942.90
188,984.50
144,426.80
ST Debt & Current Portion LT Debt
68.40
-
1,434.80
4,853.80
3,962.70
Accounts Payable
523.00
-
-
-
1,435.60
Other Current Liabilities
815.20
3,509.50
3,885.20
4,832.10
1,439.80
Total Current Liabilities
1,406.60
3,509.50
5,320.00
9,685.90
6,838.10
Long-Term Debt
-
-
8,503.10
3,841.10
-
Deferred Taxes
7,588.60
13,433.80
13,433.80
13,433.80
4,057.50
Other Liabilities
-
7.70
-
-
41,205.50
Total Liabilities
8,995.20
16,950.90
27,256.80
26,960.70
57,387.10
Common Equity (Total)
20,179.60
51,499.60
55,319.60
105,982.20
131,597.40
Total Shareholders' Equity
20,179.60
51,499.60
55,319.60
105,982.20
131,597.40
Total Equity
20,179.60
51,499.60
55,319.60
105,982.20
131,597.40
Liabilities & Shareholders' Equity
29,174.80
68,450.50
82,576.40
132,942.90
188,984.50

About Minerva Neurosciences

View Profile
Address
1601 Trapelo Road
Waltham Massachusetts 02451
United States
Employees -
Website http://www.minervaneurosciences.com
Updated 07/08/2019
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.